This site is for customers in Asia.
Customers in China & other regions, please go to Global page.
HOME > Product search results
Product
[-] MHC tetramer（218）
>Class I（218）
Refine your search
[+]Animal species
[+]Category
[+]Conjugate
[+]MHC Allele
[+]Research area
[+]Tools
[+]Brands
[+]Availability (in Japan)
MHC tetramer（218）
| Clip | Code No. | Product | Data | |||
|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
| Sequence | Location (aa) | Storage
temp. |
||||
|
|
||||||
|
TB-0167-2 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-APC |
|
|||
| cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
||
| RYCNLEGPPI | 177-186 | 4°C | ||||
|
|
TB-0157-2 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| RMPEAAPPV | 65-73 | 4°C | ||||
|
|
TB-0013-1 |
iTAg Tetramer/PE - HLA-A*02:01 gp100 (IMDQVPFSV)
|
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| IMDQVPFSV | 209-217 | 4°C | ||||
|
|
TB-0120-1 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| YLEPGPVTV | 4°C | |||||
|
|
TB-M014-4 |
HLA-A*24:02 modified WT1 Tetramer-CYTWNQMNL-BV421 |
|
|||
| cancer | BV421 | A*24:02 | 50 tests |
0 (Contact us) |
||
| CYTWNQMNL | 235-243 | 4°C | ||||
|
|
TB-0157-4 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| RMPEAAPPV | 65-73 | 4°C | ||||
|
|
TB-M070-4 |
HLA-A*02:01 MAGE-A1 Tetramer-KVLEYVIKV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| KVLEYVIKV | 278-286 | 4°C | ||||
|
|
TB-M016-4 |
T-Select HLA-A*02:01 WT-1126-134 Tetramer-RMFPNAPYL-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| RMFPNAPYL | 126-134 | 4°C | ||||
|
|
TB-M076-2 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| FLWGPRALV | 271-279 | 4°C | ||||
|
|
TB-0017-4 |
T-Select HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| VLQELNVTV | 169-177 | 4°C | ||||
|
|
TB-0161-4 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| VLAGGFFLL | 27-38 | 4°C | ||||
|
|
TB-0166-2 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-APC |
|
|||
| cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
||
| ALLAVGATK | 4°C | |||||
|
|
TB-0110-1 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| SLLFLLFSL | 4°C | |||||
|
|
TB-M105-4 |
HLA-A*02:01 NY-ESO-1 C9V Tetramer-SLLMWITQV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| SLLMWITQV | 157-165 | 4°C | ||||
|
|
TB-0159-2 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| SLPPPGTRV | 149-157 | 4°C | ||||
|
|
TB-0140-1 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-PE |
|
|||
| cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
||
| EYILSLEEL | 298-306 | 4°C | ||||
|
|
TB-0139-1 |
HLA-A*24:02 PSA Tetramer-CYASGWGSI-PE |
|
|||
| cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
||
| CYASGWGSI | 153-161 | 4°C | ||||
|
|
TB-0129-1 |
HLA-B*35:01 NY-ESO-1 Tetramer-MPFATPMEA-PE |
|
|||
| cancer | PE | B*35:01 | 50 tests |
0 (Contact us) |
||
| MPFATPMEA | 94-102 | 4°C | ||||
|
|
TB-0127-2 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| AILALLPAL | 105-133 | 4°C | ||||
|
|
TS-M079-2 |
HLA-A*02:01 SSX-2 Tetramer-KASEKIFYV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KASEKIFYV | 41-49 | 4°C | ||||
|
|
TS-M083-1 |
HLA-A*02:01 HM1.24 Tetramer-KLQDASAEV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLQDASAEV | 126-134 | 4°C | ||||
|
|
TS-M112-2 |
HLA-A*24:02 CA9219-227 Tetramer-EYRALQLHL-APC |
|
|||
|
|
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| EYRALQLHL | 219-227 | 4°C | ||||
|
|
TB-M120-1 |
HLA-A*02:01 PSA 141-150 Tetramer-FLTPKKLQCV-PE
|
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| FLTPKKLQCV | 141-150 | 4°C | ||||
|
|
TB-0113-4 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| YLFFYRKSV | 4°C | |||||
|
|
TB-0016-4 |
T-Select HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| RLLQETELV | 689-697 | 4°C | ||||
|
|
TB-0014-4 |
T-Select HLA-A*02:01 gp100 (Wild) Tetramer-ITDQVPFSV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| ITDQVPFSV | 209-217 | 4°C | ||||
|
|
TB-0013-4 |
T-Select HLA-A*02:01 gp100 (mutant) Tetramer-IMDQVPFSV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| IMDQVPFSV | 209-217 | 4°C | ||||
|
|
TB-0158-2 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| SLFLGILSV | 188-196 | 4°C | ||||
|
|
TB-0140-4 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-BV421 |
|
|||
| cancer | BV421 | A*24:02 | 50 tests |
0 (Contact us) |
||
| EYILSLEEL | 298-306 | 4°C | ||||
|
|
TB-0127-1 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| AILALLPAL | 105-133 | 4°C | ||||
|
|
TB-0113-1 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| YLFFYRKSV | 4°C | |||||
|
|
TB-0108-1 |
HLA-A*03:01 Survivin 18-27 (modK) Tetramer-RISTFKNWPK-PE |
|
|||
| cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
||
| RISTFKNWPK | 4°C | |||||
|
|
TB-0139-2 |
HLA-A*24:02 PSA Tetramer-CYASGWGSI-APC |
|
|||
| cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
||
| CYASGWGSI | 153-161 | 4°C | ||||
|
|
TB-0119-2 |
HLA-B*07:02 Tyrosinase Tetramer-LPWHRLFLL-APC |
|
|||
| cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
||
| LPWHRLFLL | 208-216 | 4°C | ||||
|
|
TS-M081-1 |
HLA-A*02:01 p53 Tetramer-LLGRNSFEV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests | 1-9 | |
| LLGRNSFEV | 264-272 | 4°C | ||||
|
|
TS-M089-2 |
HLA-A*24:02 gp100-intron 4 Tetramer-VYFFLPDHL-APC |
|
|||
|
|
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| VYFFLPDHL | 170-178 | 4°C | ||||
|
|
TB-0105-4 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-BV421 |
|
|||
| cancer | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
||
| KLFGVLRLK | 4°C | |||||
|
|
TB-0105-2 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-APC |
|
|||
| cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
||
| KLFGVLRLK | 4°C | |||||
|
|
TB-0105-1 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-PE |
|
|||
| cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
||
| KLFGVLRLK | 4°C | |||||
|
|
TB-0035-4 |
T-Select HLA-A*02:01 gp100 154-162 Tetarmer-KTWGQYWQV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| KTWGQYWQV | 154-162 | 4°C | ||||
|
|
TB-0017-1 |
T-Select HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| VLQELNVTV | 169-177 | 4°C | ||||
|
|
TB-0155-1 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| LTLGEFLKL | 96-104 | 4°C | ||||
|
|
TB-0151-4 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| GLQHWVPEL | 97-106 | 4°C | ||||
|
|
TB-0150-4 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| GLLGASVLGL | 674-683 | 4°C | ||||
|
|
TB-0132-4 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| FLYDDNQRV | 828-836 | 4°C | ||||
|
|
TS-M073-2 |
HLA-A*24:02 MAGE-A2 Tetramer-EYLQLVFGI-APC |
|
|||
|
|
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| EYLQLVFGI | 156-164 | 4°C | ||||
|
|
TB-0166-1 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-PE |
|
|||
| cancer | PE | A*03:01 | 50 tests |
0 (Contact us) |
||
| ALLAVGATK | 4°C | |||||
|
|
TB-0120-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| YLEPGPVTV | 4°C | |||||
|
|
TB-0019-4 |
T-Select HLA-A*02:01 Tyrosinase Tetramer-YMDGTMSQV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| YMDGTMSQV | 368-376 | 4°C | ||||
|
|
TB-0169-4 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| GVRGRVEEI | bcr-abl fusion protein | 4°C | ||||
|
|
TB-0134-4 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| FVGEFFTDV | 144-152 | 4°C | ||||
|
|
TB-0126-4 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-BV421 |
|
|||
| cancer | BV421 | A*01:01 | 50 tests |
0 (Contact us) |
||
| KSDICTDEY | 243-251 | 4°C | ||||
|
|
TB-0119-1 |
HLA-B*07:02 Tyrosinase Tetramer-LPWHRLFLL-PE |
|
|||
| cancer | PE | B*07:02 | 50 tests |
0 (Contact us) |
||
| LPWHRLFLL | 208-216 | 4°C | ||||
|
|
TS-M112-1 |
HLA-A*24:02 CA9219-227 Tetramer-EYRALQLHL-PE |
|
|||
|
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| EYRALQLHL | 219-227 | 4°C | ||||
|
|
TB-0114-1 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| YLQVNSLQTV | 4°C | |||||
|
|
TB-0017-2 |
T-Select HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| VLQELNVTV | 169-177 | 4°C | ||||
|
|
TB-0015-4 |
T-Select HLA-A*02:01 Her-2/neu E75 Tetramer-KIFGSLAFL-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| KIFGSLAFL | 369-377 | 4°C | ||||
|
|
TB-0155-2 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| LTLGEFLKL | 96-104 | 4°C | ||||
|
|
TB-0153-1 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| LLLTVLTVV | 13-21 | 4°C | ||||
|
|
TB-0158-1 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| SLFLGILSV | 188-196 | 4°C | ||||
|
|
TB-0156-4 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| QLCPICRAPV | 175-184 | 4°C | ||||
|
|
TB-0152-2 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| KLCPVQLWV | 139-147 | 4°C | ||||
|
|
TB-0152-1 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| KLCPVQLWV | 139-147 | 4°C | ||||
|
|
TB-0151-2 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| GLQHWVPEL | 97-106 | 4°C | ||||
|
|
TB-0136-2 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| GLAPPQHLIRV | 187-197 | 4°C | ||||
|
|
TB-0136-1 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| GLAPPQHLIRV | 187-197 | 4°C | ||||
|
|
TB-0129-4 |
HLA-B*35:01 NY-ESO-1 Tetramer-MPFATPMEA-BV421 |
|
|||
| cancer | BV421 | B*35:01 | 50 tests |
0 (Contact us) |
||
| MPFATPMEA | 94-102 | 4°C | ||||
|
|
TB-0127-4 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| AILALLPAL | 105-133 | 4°C | ||||
|
|
TB-0126-1 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-PE |
|
|||
| cancer | PE | A*01:01 | 50 tests |
0 (Contact us) |
||
| KSDICTDEY | 243-251 | 4°C | ||||
|
|
TS-M071-2 |
HLA-B*07:02 MAGE-A1 Tetramer-RVRFFFPSL-APC |
|
|||
|
|
cancer | APC | B*07:02 | 50 tests | 1-9 | |
| RVRFFFPSL | 289-297 | 4°C | ||||
|
|
TS-M079-1 |
HLA-A*02:01 SSX-2 Tetramer-KASEKIFYV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KASEKIFYV | 41-49 | 4°C | ||||
|
|
TS-M084-1 |
HLA-A*02:01 EphA2 Tetramer-TLADFDPRV-PE |
|
|||
|
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| TLADFDPRV | 883-891 | 4°C | ||||
|
|
TB-M075-2 |
HLA-A*02:01 MAGE-A3 112-120 Tetramer-KVAELVHFL-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| KVAELVHFL | 112-120 | 4°C | ||||
|
|
TB-0120-2 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| YLEPGPVTV | 4°C | |||||
|
|
TB-0108-2 |
HLA-A*03:01 Survivin 18-27 (modK) Tetramer-RISTFKNWPK-APC |
|
|||
| cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
||
| RISTFKNWPK | 4°C | |||||
|
|
TB-0158-4 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| SLFLGILSV | 188-196 | 4°C | ||||
|
|
TB-0156-2 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| QLCPICRAPV | 175-184 | 4°C | ||||
|
|
TB-0139-4 |
HLA-A*24:02 PSA Tetramer-CYASGWGSI-BV421 |
|
|||
| cancer | BV421 | A*24:02 | 50 tests |
0 (Contact us) |
||
| CYASGWGSI | 153-161 | 4°C | ||||
|
|
TB-0134-2 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| FVGEFFTDV | 144-152 | 4°C | ||||
|
|
TB-0132-2 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| FLYDDNQRV | 828-836 | 4°C | ||||
|
|
TS-M083-2 |
HLA-A*02:01 HM1.24 Tetramer-KLQDASAEV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLQDASAEV | 126-134 | 4°C | ||||
|
|
TS-M084-2 |
HLA-A*02:01 EphA2 Tetramer-TLADFDPRV-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| TLADFDPRV | 883-891 | 4°C | ||||
|
|
TB-M082-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| YLEPGPVTA | 280-288 | 4°C | ||||
|
|
TB-0166-4 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-BV421 |
|
|||
| cancer | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
||
| ALLAVGATK | 4°C | |||||
|
|
TB-0114-4 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| YLQVNSLQTV | 4°C | |||||
|
|
TB-0112-4 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| VLPLTVAEV | 4°C | |||||
|
|
TB-0112-1 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| VLPLTVAEV | 4°C | |||||
|
|
TB-0159-4 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| SLPPPGTRV | 149-157 | 4°C | ||||
|
|
TB-0126-2 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-APC |
|
|||
| cancer | APC | A*01:01 | 50 tests |
0 (Contact us) |
||
| KSDICTDEY | 243-251 | 4°C | ||||
|
|
TS-M078-2 |
HLA-A*02:01 MAGE-A10 Tetramer-GLYDGMEHL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLYDGMEHL | 254-262 | 4°C | ||||
|
|
TS-M095-2 |
HLA-A*02:01 PP2A Tetramer-SLLPAIVEL-APC |
|
|||
|
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLLPAIVEL | 402-410 | 4°C | ||||
|
|
TB-0114-2 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| YLQVNSLQTV | 4°C | |||||
|
|
TB-0112-2 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| VLPLTVAEV | 4°C | |||||
|
|
TB-0155-4 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| LTLGEFLKL | 96-104 | 4°C | ||||
|
|
TB-0153-4 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-BV421 |
|
|||
| cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
| LLLTVLTVV | 13-21 | 4°C | ||||
|
|
TB-0164-1 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| YMCSFLFNL | 666-674 | 4°C | ||||
|
|
TB-0163-2 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-APC |
|
|||
| cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
| YLGSYGFRL | 103-111 | 4°C | ||||
|
|
TB-0163-1 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| YLGSYGFRL | 103-111 | 4°C | ||||
|
|
TB-0156-1 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| QLCPICRAPV | 175-184 | 4°C | ||||
|
|
TB-0151-1 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-PE |
|
|||
| cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
| GLQHWVPEL | 97-106 | 4°C | ||||
- The availability is based on the information in Japan at 17:00, May 14, 2024 in JST.
- The special price is shown in red color.
- Please note that products cannot be ordered from this website. To purchase the items listed in this website, please contact us or local distributers.
- For storage temparature: RT: room temparature
- Please note that products in this website might be changed or discontinued without notification in advance for quality improvement.